Influenza, pneumococcus, and herpes zoster vaccination among patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and inflammatory bowel disease, and the effect of reminders on vaccination rates in Australian general practice
- Conditions
- InfluenzaPneumococcusHerpes ZosterRheumatoid arthritisInflammatory bowel diseasePsoriatic arthritisAnkylosing spondylitisCrohn's DiseasePublic Health - Health promotion/educationInflammatory and Immune System - Rheumatoid arthritis
- Registration Number
- ACTRN12619001221145
- Lead Sponsor
- The University of Adelaide
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 1903
All patients with immune-mediated inflammatory diseases (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or inflammatory bowel disease) from Australian general practices using the DCP software that agreed to be part of this study. All GPs and registered nurses from participant practices will be invited to a training session about appropriate vaccinations for patients with immune-mediated inflammatory diseases.
Patients who have already received the immunisations of interest, patients with contraindication to the relevant vaccine. All GPs and registered nurses who do not accept to participate in the educational activities.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in influenza immunisation status according to electronic medical records[18 months from the beginning of the study];Change in pneumococcus immunisation according to electronic medical records[18 months from the beginning of the study];Change in herpes zoster immunisation status according to electronic medical records[18 months from the beginning of the study]
- Secondary Outcome Measures
Name Time Method Change in GPs and registered nurses confidence in vaccination recommendations for patients with immune-mediated inflammatory conditions through educational activities, which will be evaluated through interviews and/or focus groups, using a semi-structured questionnaire designed specifically for this study.[First questionnaire/interview will happen in the beginning of the study (before the use of reminders), the second one soon after the educational activity, and the last one in the end of the study (18 months form the beginning of the study).]